Tandem Diabetes Care
TNDM
TNDM
246 hedge funds and large institutions have $1.65B invested in Tandem Diabetes Care in 2023 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 87 increasing their positions, 89 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
40% less capital invested
Capital invested by funds: $2.77B → $1.65B (-$1.12B)
42% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 62
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
246
Holding in Top 10
–
Calls
$4.58M
Puts
$6.95M
Top Buyers
| 1 | +$30.1M | |
| 2 | +$19.4M | |
| 3 | +$18.5M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$16.1M |
| 5 |
EC
Eminence Capital
New York
|
+$15.9M |
Top Sellers
| 1 | -$90.3M | |
| 2 | -$40.6M | |
| 3 | -$17M | |
| 4 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$14.2M |
| 5 |
Morgan Stanley
New York
|
-$13M |